The Changing Landscape of Intermediate- and Poor-Risk Germ Cell Tumors: Do We Need to Reclassify Patients With Metastatic Germ Cell Tumors?

MeSH terms

• Humans
• Male
• Neoplasms, Germ Cell and Embryonal / classification*
• Neoplasms, Germ Cell and Embryonal / diagnosis
• Neoplasms, Germ Cell and Embryonal / drug therapy
• Neoplasms, Germ Cell and Embryonal / secondary
• Prognosis
• Randomized Controlled Trials as Topic
• Risk
• Testicular Neoplasms / classification*
• Testicular Neoplasms / diagnosis
• Testicular Neoplasms / drug therapy
• Testicular Neoplasms / pathology